retatrutide clinical trials weight loss retatrutide VisualAbstract: reduces body by 17.5% in patients with obesity New Weight Loss Drug Retatrutide:

Many people expect immediate results when starting a weight-loss medication

Food and Drug Administration or any other regulatory authority for human or veterinary use, diagnosis, or treatment of any condition

A small addition can significantly change the outcome

you have established consistent protein intake and resistance exercise habits

This includes eligibility screening, dose titration, a critical phase in tirzepatide therapy where doses advance from the 2.5 mg starting dose through escalating levels (5 mg, 7.5 mg, 10 mg, and 12.5 mg or 15 mg), and ongoing monitoring of metabolic and clinical outcomes

The announcement comes a day after Eli Lilly and Novo Nordisk shares moved in opposite directions following their latest earnings reports, as Novo Nordisk warned of sales could decline this year, while Eli Lilly said its sales are expected to keep growing